Many people are not aware of the term “cancer epidemiology.” It refers to the study of the factors that affect cancer. This study is an effective way to determine the possible causes and modern trends associated with the condition. This study deploys epidemiological techniques to assess how cancer is caused to be detected for the development of better treatments for patients.
Dr. Paolo Boffetta is a respected name in the field of cancer epidemiology across the globe. His hometown is in Turin, Italy, and he currently resides in New York. He joined Mount Sinai School of Medicine in 2010 and is the Director of the Institute for Translational Epidemiology and Associate Director for Population Sciences of The Tisch Cancer Institute. He is the Bluhdorn Professor of International Community Medicine. In the past, he has been associated with the American Cancer Society in New York, Columbia University (NY), the American Cancer Society in New York, the International Agency for Research on Cancer at Lyon in France, and the German Cancer Research Center at Heidelberg in Germany.
Dr. Boffetta is also the Adjunct Professor at the Department of Epidemiology, Harvard School of Public Health at Boston in Massachusetts, Department of Medicine, Vanderbilt University at Nashville in Tennessee, and a Visiting Professor at the Department of Biomedical Sciences and Human Oncology, the University of Turin located at Turin in Italy. He is the Senior Fellow of the Hellenic Health Foundation at Athens in Greece and holds several prestigious posts with medical establishments worldwide.
Coming back to the subject of cancer epidemiology, he has observed in his research and studies that on an average there are 40% of both men and women in the USA who are diagnosed at some point in their life with cancer. In recent years, there have been theatrical developments that give medical professionals a more in-depth insight into cancer development and its progression in the last few decades.
Improvements in cancer screening and its treatment methods
Thanks to the above research on cancer epidemiology, there have been breakthroughs in cancer patients’ screening and treatment. There are a large number of cancer survivors that live beyond the first diagnosis.
There is evidence of epidemiology factors that are related to lifestyle risks for cancer. There is an estimation that almost 1/3rd to a ½ of cancers can be prevented with healthy lifestyle choices. These choices are changes in food habits, exercise, and sleep. They are simple changes that go the extra mile when it comes to the prevention of cancer.
Dr.Paolo Boffetta states that if more and more people are aware of these risk factors that cause cancer, they can successfully prevent the condition. More awareness needs to be spread. Though there have been breakthroughs in cancer treatment, there is still a lot more to be done to make people aware of how simple lifestyle changes can prevent the condition and save them from the dreaded impact of cancer taking over the lives with success!